These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7042537)

  • 1. Neoplastic B cells as targets for antibody-ricin A chain immunotoxins.
    Vitetta ES; Krolick KA; Uhr JW
    Immunol Rev; 1982; 62():159-83. PubMed ID: 7042537
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotoxins: hybrid molecules combining high specificity and potent cytotoxicity.
    Jansen FK; Blythman HE; Carrière D; Casellas P; Gros O; Gros P; Laurent JC; Paolucci F; Pau B; Poncelet P; Richer G; Vidal H; Voisin GA
    Immunol Rev; 1982; 62():185-216. PubMed ID: 7042538
    [No Abstract]   [Full Text] [Related]  

  • 3. The preparation and cytotoxic properties of antibody-toxin conjugates.
    Thorpe PE; Ross WC
    Immunol Rev; 1982; 62():119-58. PubMed ID: 7042536
    [No Abstract]   [Full Text] [Related]  

  • 4. Eradication of murine lymphoma and melanoma cells by chlorambucil-antibody complexes.
    De Weger RA; Dullens HF; Den Otter W
    Immunol Rev; 1982; 62():28-45. PubMed ID: 7042539
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of antibody valency and lysosomotropic amines on the synergy between ricin A chain- and ricin B chain-containing immunotoxins.
    Fulton RJ; Uhr JW; Vitetta ES
    J Immunol; 1986 Apr; 136(8):3103-9. PubMed ID: 3958490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bispecific antibody that binds carcinoembryonic antigen and ricin toxin A chain cytotoxic for gastrointestinal tract tumor cells.
    Robins RA; Embleton MJ; Pimm MV; Betts DS; Charleston A; Markham AJ; Baldwin RW
    J Natl Cancer Inst; 1990 Aug; 82(15):1295-6. PubMed ID: 2374178
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer.
    Wawrzynczak EJ; Derbyshire EJ; Henry RV; Parnell GD; Smith A; Waibel R; Stahel RA
    Br J Cancer Suppl; 1991 Jun; 14():71-3. PubMed ID: 1645577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of immunotoxins containing ricin A or B chains to kill neoplastic B cells.
    Vitetta ES; Uhr JW
    Ann N Y Acad Sci; 1985; 446():228-36. PubMed ID: 3860153
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
    Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
    Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo therapy of the BCL1 tumor: effect of immunotoxin valency and deglycosylation of the ricin A chain.
    Fulton RJ; Uhr JW; Vitetta ES
    Cancer Res; 1988 May; 48(9):2626-31. PubMed ID: 3258547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective cytotoxicity of a ricin A-chain-anti-carcinoembryonic antigen antibody conjugate for a human colon adenocarcinoma cell line.
    Griffin TW; Haynes LR; DeMartino JA
    J Natl Cancer Inst; 1982 Oct; 69(4):799-805. PubMed ID: 6956757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody-ricin or ricin A chain hybrids: kinetic analysis of cell killing for tumor therapy.
    Neville DM; Youle RJ
    Immunol Rev; 1982; 62():75-91. PubMed ID: 7042541
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cytotoxicity of a conjugate of ricin A-chain and monoclonal anti-allotypic antibody].
    Rachmanova VA; Tonevitskiĭ AG; Cherapakhin VV; Bobreneva RA
    Biull Eksp Biol Med; 1988 May; 105(5):568-70. PubMed ID: 3132992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells.
    Vitetta ES; Cushley W; Uhr JW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6332-5. PubMed ID: 6578512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo efficacy of conjugates of daunomycin with anti-tumor antibodies.
    Arnon R; Sela M
    Immunol Rev; 1982; 62():5-27. PubMed ID: 7042540
    [No Abstract]   [Full Text] [Related]  

  • 16. Binding and cytotoxic effect of ricin toxin on multivalent hybrid antibody-coated target cells.
    Laky M; Mota G; Moraru I; Ghetie V
    Immunol Lett; 1987 Jan; 14(2):127-32. PubMed ID: 3495487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selective cytotoxicity of antibody-ricin-A-chain conjugate for human tumor B cells. II. Comparison of activity of immunotoxins conjugated with poly- and monoclonal antibodies].
    Tonevitskiĭ AG; Zhukova OS; Rakhmanova VA; Arsen'eva EL; Bogacheva GT
    Mol Biol (Mosk); 1988; 22(4):911-6. PubMed ID: 3141780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytotoxic properties of an immunotoxin interacting with mouse myeloma cells].
    Tonevitskiĭ AG; Trakht IN
    Dokl Akad Nauk SSSR; 1984; 277(3):756-9. PubMed ID: 6386405
    [No Abstract]   [Full Text] [Related]  

  • 19. Whole ricin and recombinant ricin A chain idiotype-specific immunotoxins for therapy of the guinea pig L2C B cell leukemia.
    Gregg EO; Bridges SH; Youle RJ; Longo DL; Houston LL; Glennie MJ; Stevenson FK; Green I
    J Immunol; 1987 Jun; 138(12):4502-8. PubMed ID: 3495593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to purified ricin A-chain: production and properties.
    Leonard JE; Tanney LE; Collins ML; Royston I; Taetle R
    Hybridoma; 1987 Apr; 6(2):135-49. PubMed ID: 3570304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.